Statins go head to head
July 1, 1998 less than 1 minute read
Statins go head to head
Because of heated competition from Warner-Lambert's Lipitor, Merck is deeply discounting to 1,200 hospitals its anticholesterol drug Zocor. The normal wholesale price is $1.88 to $3.40 per tablet, and the company is offering the drug for "pennies a day." In return, the hospitals must ensure that a certain percentage of the drugs they prescribe are either Zocor or Mevacor, other Merck products. The slash-and-burn marketing technique may prompt other statin companies to cut their prices, and the one benefiting most may be you.
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content